Unlock instant, AI-driven research and patent intelligence for your innovation.

Vaccines from infectious agents

A vaccine composition and selected technology, which can be used in anti-infective drugs, anti-infective drugs, genetic engineering and other directions, and can solve problems such as undetermined properties of peptide fragments

Inactive Publication Date: 2009-08-05
IMMUNOBIOLOGY LTD
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, the nature of these peptide fragments has not been determined

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1: Preparation of heat-induced HSPs

[0032] The cells of the extracellular pathogen Mycobacterium bovis (BCG) were cultured at 37°C to stationary phase with conventional medium, heat-shocked at 42°C for 0.5 hours, or at 39°C for 5 hours, and cultured overnight to induce heat-shock-containing cells. Formation of products of protein and antigenic peptide fragments. Pathogen cells are then washed in phosphate-buffered saline (PBS) and resuspended in a homogenization buffer, especially a hypotonic buffer, such as containing 2 mM MgCl 2 10mM phosphate, pH7.4. The cells are then disrupted by any suitable technique, e.g. with a cell homogenizer (e.g. French press, Ultraturrax or Waring mixer), lysed with detergents such as Tween or Triton, complement lysed at 37°C, or re-frozen, e.g. in liquid nitrogen melt. Cell lysates are then processed by centrifugation, typically at 3-5000g for 5 minutes to remove nuclei and cell debris, followed by high-speed centrifugation a...

Embodiment 2

[0036] Example 2: Immunization with induced HSPs; immunity in vaccine recipients

[0037] Vaccine compositions containing HSP complexes were prepared as described in Example 1. Mice and rabbits were vaccinated by injecting 1-10 μg of stress protein complexes in phosphate buffered saline, with the same dose one month after the initial injection. vaccine booster. Immunity induced by pathogens was analyzed by Western blot using total M. bovis proteins. Antibody titers of 1:1-10000 are usually obtained, and cytotoxic T cell activity against pathogen-infected cells can also be detected in immunized mice. Challenge with fixed M. bovis at 6, 12 and 18 months after primary immunization resulted in good antibody responses with titers ranging from 1:1 to 10,000, indicating a good memory response in immunized animals.

Embodiment 3

[0038] Example 3 Comparison of Peptides Binded in Constitutive and Induced HSP Complexes

[0039] M. tuberculosis was grown to saturation in Sauton's medium at 37°C for 3 days. A 4 ml aliquot of the stationary culture was used to inoculate 500 ml of Sauton's medium in 2 liter Erlenmeyer flasks, and the culture was grown overnight at 30°C. The temperature of the log phase culture was then raised to 40°C and grown for an additional 4 hours before the bacteria were harvested by centrifugation at 10000 rpm for 10 minutes. Non-induced (constitutive) HSPs were isolated from initial cell cultures by centrifugation at 37°C.

[0040] Cell pellets from centrifuged samples were resuspended in lysate containing 0.5% Tween and HSPs prepared from induced and non-induced cells by ammonium sulfate precipitation as described in Example 1. Purified HSPs were resuspended in 10% acetic acid and boiled for 15 minutes to elute HSP-bound peptides. Denatured HSPs were precipitated in a Beckman air...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a method for producing and isolating specific immunogenic endogenous heat shock proteins induced by the treatment of extra-cellular pathogens with stress inducing stimuli and vaccines prepared from such proteins.

Description

[0001] The present invention relates to a vaccine and a method of producing the vaccine. More particularly, the present invention relates to methods of producing vaccine compositions comprising stress-induced proteins from extracellular pathogenic organisms. Background of the invention [0002] An important component of any human immune response is the presentation of antigens to T cells by antigen presenting cells (APCs) such as macrophages, B cells or dendritic cells. Peptide fragments of exogenous antigens are presented on the surface of macrophages together with major histocompatibility complex (MHC) molecules via association with accessory molecules such as CD4 and CD8 molecules. Such antigenic peptide fragments presented in this manner are recognized by T cell receptors of T cells. Interaction of antigenic peptide fragments with T cell receptors results in proliferation of antigen-specific T cells and secretion of lymphokines by T cells. The nature of the antigenic pep...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/31C07K14/315C12N1/21C07K16/12A61K39/09A61K39/395G01N33/569C12Q1/68A61P31/00A61P31/04A61K39/00A61KA61K39/002A61K39/005A61K39/02A61K39/04A61K39/108A61P31/10A61P33/02A61P37/04
CPCA61K39/0275A61K39/0258A61K2039/6043A61P31/00A61P31/04A61P31/10A61P33/02A61P37/04Y02A50/30
Inventor 卡米洛·安东尼·利奥·塞尔温·科拉科
Owner IMMUNOBIOLOGY LTD